Similar articles

• Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.

  Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, Tanew A. Radakovic S, et al. J Eur Acad Dermatol Venereol. 2009 Aug;23(8):951-3. doi: 10.1111/j.1468-3083.2009.03138.x. Epub 2009 Jun 2. J Eur Acad Dermatol Venereol. 2009. PMID: 19496898 Clinical Trial.
• Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment.

  Ahn BK, Kim BD, Lee SJ, Lee SH. Ahn BK, et al. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):532-3. doi: 10.1016/j.jaad.2004.09.037. J Am Acad Dermatol. 2005. PMID: 15761441 No abstract available.
• Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color.

  Silverberg JI, Silverberg NB. Silverberg JI, et al. J Drugs Dermatol. 2011 May;10(5):507-10. J Drugs Dermatol. 2011. PMID: 21533297
• Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.

  García DP, Alperte JI, Cristóbal JA, Mateo Orobia AJ, Muro EM, Valyi Z, Del Rio BJ, Arnao MR. García DP, et al. Cornea. 2011 Apr;30(4):462-5. doi: 10.1097/ICO.0b013e3181d83875. Cornea. 2011. PMID: 20861732 Review.
• Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment.

  Wilsmann-Theis D, Hagemann T, Dederer H, Wenzel J, Bieber T, Novak N. Wilsmann-Theis D, et al. Br J Dermatol. 2004 Jun;150(6):1194-7. doi: 10.1111/j.1365-2133.2004.05992.x. Br J Dermatol. 2004. PMID: 15214910 Review.